Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

LifeStance Health (LFST) EBITDA Margin: 2019-2024

Historic EBITDA Margin for LifeStance Health (LFST) over the last 5 years, with FY2024 value amounting to 4.7%.

  • LifeStance Health's EBITDA Margin rose 27000.0% to 0.2% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.72%, marking a year-over-year increase of 74800.0%. This contributed to the annual value of 4.7% for FY2024, which is 130300.0% up from last year.
  • LifeStance Health's EBITDA Margin amounted to 4.7% in FY2024, which was up 130300.0% from 17.74% recorded in FY2023.
  • LifeStance Health's 5-year EBITDA Margin high stood at 4.7% for FY2024, and its period low was 46.02% during FY2021.
  • Moreover, its 4-year median value for EBITDA Margin was 21.22% (2022), whereas its average is 23.29%.
  • In the last 5 years, LifeStance Health's EBITDA Margin surged by 213200bps in 2022 and then skyrocketed by 69600bps in 2023.
  • Over the past 4 years, LifeStance Health's EBITDA Margin (Annual) stood at 46.02% in 2021, then skyrocketed by 46bps to 24.7% in 2022, then increased by 28bps to 17.74% in 2023, then surged by 73bps to 4.7% in 2024.
  • Its EBITDA Margin stands at 4.7% for FY2024, versus 17.74% for FY2023 and 24.7% for FY2022.